Do biological activities of selective histone deacetylase 6 ( HDAC6 ) inhibitors rely on the modification of cap group?
Journal of Molecular Recognition · 2022-12 · 35 (12)
DOI: 10.1002/jmr.2988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Recognition, online erschienen am 19.08.2022. Verfasst von Xingang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Molecular Dynamics Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Department of Education of Hebei Province, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Nowadays, significant progress has been made in the development of selective histone deacetylase 6 (HDAC6) inhibitors, exerting great potential in the treatment of various malignant tumors and neurodegenerative diseases. Previously, selective inhibitory activities of HDAC inhibitors were generally considered sensitive to the interactions between the Cap group and the binding site of HDAC6, and a large number of selective HDAC6 inhibitors have been designed and synthesized based on the strategy. However, some inhibitors without Cap group could also exhibit excellent potency and selective inhibition towards HDAC6, and in this study, BRD9757 and compound 8 , as capless selective HDAC6 inhibitors, were selected as molecular probes to explore the difference of their binding interactions in HDAC1&6. Through the analysis of binding‐free energies and conformational rearrangements after 1 μs molecular dynamics simulation, it could be learned that although the residues in the binding site remained highly consistent, the binding mechanisms of BRD9757 and compound 8 in HDAC1&6 were different, which will provide valuable hints for the discovery of novel selective HDAC6 inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
- Department of Pharmacology, Hebei Medical University, Shijiazhuang, China.
- Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Songsong Wang, Xuedong Li, Yang Zhang, Haisheng Liu
Förderung
- Department of Education of Hebei Province
- Natural Science Foundation of Hebei Province
Zitieren
APA
Liu, X., Wang, S., Shi, X., Lu, M., Wang, C., Li, X., Zhang, Y., Jia, Q., & Liu, H. (2022). Do biological activities of selective histone deacetylase 6 ( HDAC6 ) inhibitors rely on the modification of cap group?. Journal of Molecular Recognition, 35(12). https://doi.org/10.1002/jmr.2988
Vancouver
Liu X, Wang S, Shi X, Lu M, Wang C, Li X, et al. Do biological activities of selective histone deacetylase 6 ( HDAC6 ) inhibitors rely on the modification of cap group?. Journal of Molecular Recognition. 2022;35(12). doi:10.1002/jmr.2988
BibTeX
@article{Liu2022,
author = {Liu, Xingang and Wang, Songsong and Shi, Xiaoxing and Lu, Ming and Wang, Chengzhao and Li, Xuedong and Zhang, Yang and Jia, Qingzhong and Liu, Haisheng},
title = {Do biological activities of selective histone deacetylase 6 ( HDAC6 ) inhibitors rely on the modification of cap group?},
journal = {Journal of Molecular Recognition},
year = {2022},
volume = {35},
number = {12},
doi = {10.1002/jmr.2988}
}
EUVIMED